scPharmaceuticals Inc.

AI Score

0

Unlock

3.20
-0.08 (-2.44%)
At close: Mar 03, 2025, 3:59 PM
3.24
1.25%
After-hours: Mar 03, 2025, 06:20 PM EST

scPharmaceuticals Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -54.81M -36.84M -28.03M -32.21M -33M -29.44M -23.82M -24.38M -10.52M
Depreciation & Amortization 626K 468K 438K 399K 364K 332K 167K 5K 4K
Stock-Based Compensation 4.86M 2.84M 2.37M 2M 1.45M 2.13M 947K 876K 379K
Other Working Capital 221K -887K -234K 236K -611K -833K -1.13M -214K -85K
Other Non-Cash Items -3.6M -695K 678K 639K 385K 374K 198K 6.51M -394K
Deferred Income Tax n/a n/a n/a 30K 2K n/a n/a n/a n/a
Change in Working Capital -6.32M -350K -2.6M 1.45M 354K -2.21M -177K 1.53M 889K
Operating Cash Flow -59.24M -34.58M -27.15M -27.69M -30.44M -28.81M -22.68M -15.46M -9.64M
Capital Expenditures -40K -21K -9K n/a n/a n/a -194K -9K -17K
Acquisitions n/a 45.84M -32.14M n/a n/a n/a n/a n/a n/a
Purchase of Investments -50.59M -67.54M -9.01M -72.16M n/a n/a n/a n/a n/a
Sales Maturities Of Investments 70.6M 21.7M 41.15M 38.7M n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -45.84M 32.14M -33.46M n/a n/a n/a n/a n/a
Investing Cash Flow 19.96M -45.86M 32.13M -33.46M n/a n/a -194K -9K -17K
Debt Repayment n/a 29.8M -2.5M n/a 9.55M -62K 9.27M 12.6M n/a
Common Stock Repurchased n/a n/a -81K -164K n/a -4K -3K n/a -9K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 812K -337K -81K -228K 60K 58K 94K 40.57M 8.03M
Financial Cash Flow 14.85M 77.23M -2.53M 60.35M 13.59M -8K 102.07M 53.17M 8.02M
Net Cash Flow -24.43M -3.21M 2.45M -805K -16.85M -28.82M 79.2M 37.71M -1.64M
Free Cash Flow -59.28M -34.6M -27.16M -27.69M -30.44M -28.81M -22.88M -15.46M -9.66M